To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

Alere agrees to buy eScreen

By Chris Reidy

 |  Globe Staff  

  February 28, 2012

Alere Inc., a Waltham-based company that provides health management services, said today that it has agreed to buy eScreen Inc., a technology firm that specializes in toxicology screening and employee health products and services. The purchase price is $270 million and potential additional payments of up to $70 million, Alere said. Kansas-based eScreen had 2011 revenues of about $120 million. Among the services it offers are urine drug screens.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help